1Obrosova IG. Diabetes and the peripheral nerve[J]. Biochim Bio-phys Acta,2009,1792(10) :931-940.
2Vinik Al. Diabetic neuropathy : pathogenesis and therapy[J], Am JMed, 1999,107(2B) :17-26.
3Greene DA,Stevens MJ,Obrosova I,et al. Glucose-induced oxida-tive stress and programmed cell death in diabetic neuropathy [J].Eur J Pharmacol, 1999,375(1/3) :217-223.
4Kuzumoto Y.Kusunoki S,Kato N, et al. Effect of the aldose re-ductase inhibitor fidarestat on experimental diabetic neuropathy inthe rat[J]. Diabetologia,2006,49(12) : 3085-3093.
6Halliwell B,Gutteridge JMC. Free radicals in biology and medicine[M]. 2nd ed. Oxford,England: Clarendon Press, 1989 : 100-102.
7Russell JW,Berent-Spillson A, Vincent AM,et al. Oxidative inju-ry and neuropathy in diabetes and impaired glucose tolerance[J].Neurobiol Dis,2008,30(3) :420-429.
8Brownlee M. The pathobiology of diabetic complications: a unif-ying mechanism[J], Diabetes,2005.54(6) : 1615-1625.
9Obrosova IG. How does glucose generate oxidative stress in pe-ripheral nerve[J]. Int Rev Neurobiol,2002,50(1) :3-35.
10Julius U,Drel VR,Grassier J,et al. Nitrosylated proteins in mon-ocytes as a new marker of oxidative-nitrosative stress in diabeticsubjects with macroangiopathy[J]. Exp Clin Endocrinol Diabetes,2009,117(2):72-77.
2Annuk M, Zilmer M, Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure:impact on cardiovascular disease [J]. Kidney Int Suppl, 2003, 84: S50- S53.
3Brandes RP, Kreuzer J. Vascular NADPH oxidases., molecular mechanisms of activation [J]. Cardiovasc Res, 2005, 65(1): 16- 27.
4Mandrup-Poulsen T. Apoptotic signal transduction pathways in diabetes [J]. Biochem Pharmacol, 2003, 66(8) : 1433-1440.
5Ceriello A, Piconi L, Quagliaro L, et al. Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes [J]. Diabetes Care, 2005, 28(3): 632-637.
6Goldstein BJ, Mahadev K, Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets [J]. Diabetes, 2005, 54(2): 311-321.
7Fariss MW, Chan CB, Patel M, et al. Role of mitoehondria in toxic oxidative stress[J]. Mol Interv, 2005, 5(2): 94-111.
8Ammon-Treiber S, Stolze D, Schroder H, et al. Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model [J]. Neuropharmacology, 2005, 49(8) : 1160-1169.
9Higashi Y, Yoshizumi M. Endothelial function [J]. Nippon Rinsho, 2003, 61(7): 1138-1144.
10Vlassara H, Palace MR. Glycoxidation: the menace of diabetes and aging [J]. Mt Sinai J Med, 2003, 70(4): 232-241.